Surface marker studies in chronic lymphocytic leukaemia and Non-Hodgkin's lymphoma**Read in part at the 23rd Annual Meeting of the Royal College of Pathologists of Australia, Canberra, 4-8 September 1978.-Reference-Cited by-同舟云学术

Surface marker studies in chronic lymphocytic leukaemia and Non-Hodgkin's lymphoma**Read in part at the 23rd Annual Meeting of the Royal College of Pathologists of Australia, Canberra, 4-8 September 1978.

Published:1979 Issue:3 Volume:11 Page:461-471
ISSN:0031-3025
Container-title:Pathology
language:en
Short-container-title:Pathology

Author:

Leong A.S-Y.,Forbes I.J.,Cowled P.A.,Sage R.E.,Black R.B.,Dale B.,Zalewski P.D.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference57 articles.

1. Immunoglobulins on the surface of neoplastic lymphocytes;Aisenberg;N. Engl. J. Med,1972

2. Lymphocyte surface characteristics in malignant lymphoma;Aisenberg;Am. J. Med,1975

3. Human lymphocyte subpopulations defined by double surface markers;Bankhurst;J. Lab. Clin. Med,1978

4. Immunological diagnosis of leukaemia and lymphoma:, a World Health Organization/ International Union of Immunological Societies technical report;Belpomme;Br. J. Haemat,1978

5. Multivariate analysis of prognostic factors in non-Hodgkin's malignant lymphomas;Bloomfield;Cancer,1974

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Lymphocyte and Mouse Erythrocyte Rosettes Optimization of the Assay;Scandinavian Journal of Haematology;2009-04-24

2. A Comprehensive Antibody Panel for Immunohistochemical Analysis of Formalin-Fixed, Paraffin-Embedded Hematopoietic Neoplasms of Mice: Analysis of Mouse Specific and Human Antibodies Cross-Reactive with Murine Tissue;Toxicologic Pathology;2007-04

3. B Cell Lymphomas;Essential Oncology of the Lymphocyte;1987

4. Differentiation of Chronic Lymphocytic Leukemia from Reactive Lymphocytosis by the Mouse Red Cell Rosette Assay;International Archives of Allergy and Immunology;1984

5. A critique of some contemporary classifications of non-hodgkin’s lymphoma. Which one should we now use?;Pathology;1983